Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2001 1
2004 2
2008 1
2011 2
2012 1
2013 1
2017 2
2019 1
2021 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Locally Advanced Undifferentiated Pleomorphic Sarcoma"
Page 1
A League of Its Own? Established and Emerging Therapies in Undifferentiated Pleomorphic Sarcoma.
Graves L, Jeck WR, Grilley-Olson JE. Graves L, et al. Curr Treat Options Oncol. 2023 Mar;24(3):212-228. doi: 10.1007/s11864-023-01054-7. Epub 2023 Feb 2. Curr Treat Options Oncol. 2023. PMID: 36729198 Review.
Undifferentiated pleomorphic sarcoma (UPS), formerly known as malignant fibrous histiocytoma (MFH), is among the most common subtypes of STS arising in the trunk or extremities of adults. Administration of systemic chemotherapy is the pri …
Undifferentiated pleomorphic sarcoma (UPS), formerly known as malignant fibrous histiocytoma (MFH) …
Neutrophil-to-Lymphocyte ratio as a prognostic biomarker in extremities undifferentiated pleomorphic sarcoma.
García-Ortega DY, Melendez-Fernandez AP, Alvarez-Cano A, Clara-Altamirano MA, Caro-Sanchez C, Alamilla-Garcia G, Luna-Ortiz K. García-Ortega DY, et al. Surg Oncol. 2022 Jun;42:101746. doi: 10.1016/j.suronc.2022.101746. Epub 2022 Mar 29. Surg Oncol. 2022. PMID: 35378375
In this paper we analyzed the prognostic role of the neutrophil to lymphocyte ratio (NLR) in extremity undifferentiated pleomorphic sarcoma (eUPS). MATERIALS AND METHODS: We performed an observational, retrospective study including all eUPS cases treat …
In this paper we analyzed the prognostic role of the neutrophil to lymphocyte ratio (NLR) in extremity undifferentiated pleomorphi …
Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma.
Pan M, Zhou MY, Jiang C, Zhang Z, Bui NQ, Bien J, Siy A, Achacoso N, Solorzano AV, Tse P, Chung E, Thomas S, Habel LA, Ganjoo KN. Pan M, et al. Clin Cancer Res. 2024 Jan 17;30(2):413-419. doi: 10.1158/1078-0432.CCR-23-1990. Clin Cancer Res. 2024. PMID: 37831066 Free PMC article.
PURPOSE: To examine whether overall survival (OS) differs for male and female patients with advanced soft-tissue sarcoma (STS). EXPERIMENTAL DESIGN: The study included patients from Kaiser Permanente Northern California and Stanford Cancer Center with grade 2 and 3 …
PURPOSE: To examine whether overall survival (OS) differs for male and female patients with advanced soft-tissue sarcoma (STS) …
Isolated Limb Perfusion and Infusion for Extremity Soft Tissue Sarcoma: A Contemporary Systematic Review and Meta-Analysis.
Neuwirth MG, Song Y, Sinnamon AJ, Fraker DL, Zager JS, Karakousis GC. Neuwirth MG, et al. Ann Surg Oncol. 2017 Dec;24(13):3803-3810. doi: 10.1245/s10434-017-6109-7. Epub 2017 Oct 11. Ann Surg Oncol. 2017. PMID: 29022281 Review.
BACKGROUND: Isolated limb perfusion (ILP) and isolated limb infusion (ILI) have been variably used in recent years for the treatment of locally advanced or marginally resectable extremity soft tissue sarcomas (STSs). ...The majority underwent ILP (88%) versus 12% fo …
BACKGROUND: Isolated limb perfusion (ILP) and isolated limb infusion (ILI) have been variably used in recent years for the treatment of l …
The role of Ifosfamide-doxorubicin chemotherapy in histology-specific, high grade, locally advanced soft tissue sarcoma, a 14-year experience.
Goy BW, Syed S, Padmanabhan A, Burchette RJ, Helmstedter CS. Goy BW, et al. Radiother Oncol. 2021 Dec;165:174-178. doi: 10.1016/j.radonc.2021.10.019. Epub 2021 Nov 7. Radiother Oncol. 2021. PMID: 34758339
PURPOSE: To compare long-term outcomes of high-grade, primary soft-tissue-sarcoma (STS), using Ifosfamide-Doxorubicin vs local therapy alone, in histology-specific sarcomas. METHODS: Retrospective analysis was performed on 127 patients from 2005 to 2018, with high-g …
PURPOSE: To compare long-term outcomes of high-grade, primary soft-tissue-sarcoma (STS), using Ifosfamide-Doxorubicin vs local …
Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing.
Cornillie J, Wozniak A, Li H, Wang Y, Boeckx B, Gebreyohannes YK, Wellens J, Vanleeuw U, Hompes D, Stas M, Sinnaeve F, Wafa H, Lambrechts D, Debiec-Rychter M, Sciot R, Schöffski P. Cornillie J, et al. Mol Cancer Ther. 2019 Jun;18(6):1168-1178. doi: 10.1158/1535-7163.MCT-18-1045. Epub 2019 Apr 8. Mol Cancer Ther. 2019. PMID: 30962320
Soft-tissue sarcomas (STS) represent a heterogeneous group of rare, malignant tumors of mesenchymal origin. Reliable in vivo sarcoma research models are scarce. ...The tumor engraftment rate was 32% (61/188) and 188 patient samples generated a total of 32 PDX models …
Soft-tissue sarcomas (STS) represent a heterogeneous group of rare, malignant tumors of mesenchymal origin. Reliable in vivo sarco …
Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma.
Miller K, Goodlad JR, Brenn T. Miller K, et al. Am J Surg Pathol. 2012 Sep;36(9):1317-26. doi: 10.1097/PAS.0b013e31825359e1. Am J Surg Pathol. 2012. PMID: 22510760
Tumors with similar pathologic features but deep subcutaneous invasion, necrosis, and/or lymphovascular or perineural invasion are thought to be associated with adverse outcome and are better regarded as pleomorphic dermal sarcoma or undifferentiated pleom …
Tumors with similar pathologic features but deep subcutaneous invasion, necrosis, and/or lymphovascular or perineural invasion are thought t …
Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study.
Young RJ, Litière S, Lia M, Hogendoorn PCW, Fisher C, Mechtersheimer G, Daugaard S, Sciot R, Collin F, Messiou C, Grünwald V, Gronchi A, van der Graaf W, Wardelmann E, Judson I. Young RJ, et al. Acta Oncol. 2017 Jul;56(7):1013-1020. doi: 10.1080/0284186X.2017.1315173. Epub 2017 Apr 21. Acta Oncol. 2017. PMID: 28431480 Free article. Clinical Trial.
RESULTS: Three hundred and ten patients were included in this study. Discordance between local and central pathology opinion of tumor histology and tumor grade was observed in 98 (32%) and 122 (39%) cases, respectively. ...Patients with bone metastases had reduced O …
RESULTS: Three hundred and ten patients were included in this study. Discordance between local and central pathology opinion of tumor …
Adjuvant radiotherapy for pediatric and young adult nonrhabdomyosarcoma soft-tissue sarcoma.
Smith KB, Indelicato DJ, Knapik JA, Lagmay JP, Morris C, Kirwan JM, Zlotecki RA, Scarborough MT, Gibbs CP, Marcus RB. Smith KB, et al. Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):150-7. doi: 10.1016/j.ijrobp.2010.05.005. Epub 2011 May 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 21550181
The most common histologic tumor subtypes were synovial sarcoma in 22 patients, malignant fibrous histiocytoma in 19, and malignant peripheral nerve sheath tumor in 11 patients. ...The National Cancer Institute Common Toxicity Criteria, version …
The most common histologic tumor subtypes were synovial sarcoma in 22 patients, malignant fibrous histiocytoma i …
Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.
de Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M, Javidan J, Stricker H, Ro JY, Amin MB. de Peralta-Venturina M, et al. Am J Surg Pathol. 2001 Mar;25(3):275-84. doi: 10.1097/00000478-200103000-00001. Am J Surg Pathol. 2001. PMID: 11224597
The sarcomatoid component resembled fibrosarcoma in 54 cases, malignant fibrous histiocytoma in 44, undifferentiated sarcoma (not otherwise specified) in three with focal rhabdomyosarcomatous component in two of them. ...In a Cox proporti …
The sarcomatoid component resembled fibrosarcoma in 54 cases, malignant fibrous histiocytoma in 44, undifferentiated …
17 results